Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable ...

Veteran biotech leader with more than 15 years of experience joins as Latigo advances non-opioid pain pipeline Appointment comes as Latigo builds toward late-stage development and broader corporate ...

Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna’s Section 1498 appealIf the $1.3 billion payment is realized, ...

NEW DELHI — Delaware Governor Matt Meyer on March 2 pitched his state as a key US partner for India in advanced ...

David Rosenbaum, Ph.D., joins as Chief Development OfficerChristo Shalish joins as Chief Business OfficerBOSTON--(BUSINESS WIRE)--Syntis Bio, Inc. a clinical-stage biopharmaceutical company advancing ...

DIMERx, Inc. ("DIMERx" or "the Company"), is a clinical-stage biopharmaceutical company dedicated to addressing the public-health crisis ...

Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication.

The data we’re presenting reflects our dedication to finding better solutions for Alzheimer’s patients and their families,” said Jim Doherty, President and Chief Development Officer of Acumen. “By ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the Japanese Society for Regenerative Medicine (JSRM), advancing ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

Ginkgo Bioworks' new Ginkgo Cloud Lab interface will let researchers transition their benchwork to Ginkgo’s autonomous lab ...